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AntifungalAbstract A series of Schiff bases (1–17) and esters (18–24) of propionic acid was synthesized in
appreciable yield and characterized by physicochemical as well as spectral means. The synthesized
compounds were evaluated in vitro for their antimicrobial activity against Gram-positive bacteria
Staphylococcus aureus, Bacillus subtilis, Gram negative bacterium Escherichia coli and fungal strains
Candida albicans and Aspergillus niger by tube dilution method. Results of antimicrobial screening
indicated that besides having good antibacterial activity, the synthesized compounds also displayed
appreciable antifungal activity and compound 10 emerged as the most active antifungal agent
(pMICca and pMICan = 1.93). The results of QSAR studies demonstrated that antibacterial, anti-
fungal and overall antimicrobial activities of synthesized propionic acid derivatives were governed
by the topological parameters, Kier’s alpha ﬁrst order shape index (ja1) and valence ﬁrst order
molecular connectivity index (1vv).
ª 2013 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Despite tremendous progress in medicinal chemistry, the threat
due to infectious diseases has dramatically increased in developing
countries due to non availability of desired medicines and emer-
gence of widespread microbial resistance (Kumar et al., 2010).
The antimicrobial potential of simple organic acids viz. sor-
bic acid (Narasimhan et al., 2003), cinnamic acid (Narasimhanet al., 2004), anacardic acid (Narasimhan et al., 2006a), verat-
ric acid (Narasimhan et al., 2009), myristic acid (Narasimhan
et al., 2006b), caprylic acid (Chaudhary et al., 2008), anthra-
nilic acid (Mahiwal et al., 2012) and dodecanoic acid (Sarova
et al., 2011) is well established in the literature. In light of
the above we have planned to explore the antimicrobial poten-
tial of propionic acid in the present study. Literature reports
reveal that propionic acid and its derivatives possess a wide
spectrum of biological activities like antioxidant (Dracheva
et al., 2009), antitumour, analgesic, antimicrobial (Avetisyan
et al., 2010) and antidiabetic activities (Berzosa et al., 2011).
Quantitative structure–activity relationships (QSAR) at-
tempt to ﬁnd relationships between the molecular properties
of molecules and the biological responses they elicit when ap-
plied to a biological system. QSAR models allow the biological
properties of virtual structures to be predicted, and a more in-
formed choice of target to be selected for synthesis. The use of
S882 S. Kumar et al.computational approaches for the estimation of the activity of
various molecules as drug candidates prior to their synthesis
can save resources and accelerate drug discovery procedure
(Narang et al., 2012a).CH3CH2COOH
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synthesis of propionic acid derivatives.
Table 1 Physicochemical properties of synthesized propionic acid derivatives.
Comp. M. formula M. wt. m.p./b.p.a (C) Rf value* % Yield
1. C10H11N3O3 221 173–175 0.52
b 65.23
2. C11H14N2O2 206 107–110 0.40
b 80.64
3. C10H11ClN2O 210 121–123 0.83
b 75.27
4. C11H14N2O2 206 53–55 0.40
b 83.71
5. C10H12N2O 176 78–80 0.60
b 77.65
6. C11H14N2O3 222 140–143 0.21
b 85.76
7. C12H16N2O3 236 177–180 0.34
b 76.93
8. C11H12N2O2 204 233–235 0.30
b 66.03
9. C12H17N3O 219 222–225 0.22
b 90.12
10. C13H18N2O4 266 157–160 0.22
b 75.20
11. C11H14N2O2 206 141–143 0.23
b 89.01
12. C10H11ClN2O 210 113–115 0.81
b 80.36
13. C10H12N2O2 192 197–200 0.43
b 73.02
14. C10H11ClN2O 210 163–165 0.36
b 77.43
15. C10H11BrN2O 255 190–192 0.53
b 85.21
16. C11H14N2O 190 123–125 0.36
b 80.92
17. C12H14N2O 202 139–142 0.41
b 70.31
18. C7H14O2 130 123–125
a 0.36c 75.34
19. C10H12O2 164 143–145
a 0.51c 76.56
20. C6H12O2 116 93–95
a 0.55c 83.23
21. C8H16O2 144 117–120
a 0.27c 67.60
22. C9H16O2 156 123–125
a 0.39c 85.34
23. C10H20O3 188 130–132
a 0.77c 78.12
24. C7H14O2 130 138–139
a 0.65c 90.45
* TLC mobile Phase.
a b.p.
b Benzene.
c Hexane:acetone (1:1).
Figure 1 IR spectra of compound 1.
Synthesis, antimicrobial evaluation and QSAR studies of propionic acid derivatives S883observation in mind and in continuation of our study
in the ﬁeld of antimicrobial evaluation and QSAR studies
(Kumar et al., 2010, 2012; Judge et al., 2012; Narang
et al., 2012a,b), we hereby report the synthesis, antimicro-
bial evaluation and QSAR studies of propionic acid
derivatives.2. Results and discussion
2.1. Chemistry
A series of Schiff bases (1–17) and esters (18–24) was synthe-
sized using synthetic procedures as outlined in Scheme 1.
Figure 2 IR spectra of compound 10.
Figure 3 IR spectra of compound 17.
S884 S. Kumar et al.Esters were synthesized by a reaction of propionic acid with
different alcohols in the presence of sulphuric acid. Propionic
acid hydrazide was synthesized by the reaction of ethyl propi-
onate with hydrazine hydrate which on reaction with corre-
sponding aldehydes yielded Schiff bases of propionic acid.
All the compounds were obtained in appreciable yield and
their physicochemical characteristics are presented in Table 1.
The formation of target compounds was ascertained on the
basis of results of elemental analysis in addition to their
consistent IR and NMR spectral characteristics. IR spectra
of compounds 1, 10, 17 and 21 are given in Figs. 1–4.2.2. Antimicrobial activity
The synthesized compounds (1–24) were screened in vitro for
their antimicrobial potential against Gram-positive bacteria
Staphylococcus aureus, Bacillus subtilis, Gram negative bacte-
rium Escherichia coli and fungal strains Candida albicans and
Aspergillus niger by tube dilution method (Cappucino and
Sherman, 1999) using norﬂoxacin and ﬂuconazole as reference
drugs for antibacterial and antifungal activities, respectively.
Double strength nutrient broth I.P. and Sabouraud dextrose
broth I.P. (Pharmacopoeia of India, 2007) have been employed
Figure 4 IR spectra of compound 21.
Table 2 Antimicrobial activity of synthesized synthesized propionic acid derivatives.
Comp. Minimum inhibitory concentration (MIC, lMol/ml)
pMICsa pMICbs pMICec pMICca pMICan pMICab pMICaf pMICam
1. 1.25 1.25 0.95 1.55 1.55 1.15 1.55 1.31
2. 1.22 1.22 1.22 1.52 1.52 1.22 1.52 1.34
3. 1.23 1.53 1.23 1.53 1.23 1.33 1.38 1.35
4. 1.22 1.52 1.22 1.52 1.82 1.32 1.67 1.46
5. 1.15 1.45 1.15 1.15 1.45 1.25 1.30 1.27
6. 1.25 1.55 1.55 1.55 1.85 1.45 1.70 1.55
7. 1.28 1.58 1.28 1.88 1.58 1.38 1.73 1.52
8. 1.21 1.51 1.21 1.51 1.81 1.31 1.66 1.45
9. 0.94 1.24 0.94 1.54 1.85 1.04 1.70 1.30
10. 1.33 1.33 1.33 1.93 1.93 1.33 1.93 1.57
11. 1.22 1.22 1.22 1.52 1.52 1.22 1.52 1.34
12. 1.23 1.23 1.23 1.53 1.83 1.23 1.68 1.41
13. 1.19 1.19 1.19 1.49 1.49 1.19 1.49 1.31
14. 1.23 1.53 1.53 1.83 1.53 1.43 1.68 1.53
15. 1.61 1.61 1.61 1.61 1.91 1.61 1.76 1.67
16. 1.18 1.48 1.48 1.48 1.48 1.38 1.48 1.42
17. 1.21 1.51 1.51 1.51 1.51 1.41 1.51 1.45
18. 1.02 1.02 1.02 1.32 1.02 1.02 1.17 1.08
19. 1.42 1.72 1.12 1.42 1.72 1.42 1.57 1.48
20. 1.27 1.27 1.27 1.27 0.97 1.27 1.12 1.21
21. 1.06 1.36 1.06 1.06 1.06 1.16 1.06 1.12
22. 1.40 1.40 1.10 1.40 1.40 1.30 1.40 1.34
23. 1.18 1.48 1.48 1.78 1.48 1.38 1.63 1.48
24. 1.02 1.32 1.32 1.62 1.32 1.22 1.47 1.32
S.D. 0.14 0.17 0.19 0.20 0.28 0.13 0.21 0.14
Std 2.61a 2.61a 2.61a 2.64b 2.64b – – –
pMICsa, pMICbs, pMICec, pMICca and pMICan = log MIC in lMol/ml against different microorganisms. i.e. Staphylococcus aureus,
Bacillus subtilis, Escherichia coli, Candida albicans and Aspergillus niger, respectively.
a Norﬂoxacin.
b Fluconazole.
Synthesis, antimicrobial evaluation and QSAR studies of propionic acid derivatives S885as media for the growth of bacterial and fungal strains, respec-
tively. The results of antimicrobial activity are presented in
Table 2.Results of antibacterial study indicated that compound 15
was the most active antibacterial agent against S. aureus and
E. coli having pMICsa and pMICec values of 1.61. Against B.
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Figure 5 Structural requirements for the antimicrobial activity of synthesized propionic acid derivatives.
Table 3 QSAR descriptors used in the study.
S. no. QSAR descriptor Type
1 Log P Lipophilic
2 Zero order molecular connectivity index (0v) Topological
3 First order molecular connectivity index (1v) Topological
4 Second order molecular connectivity index (2v) Topological
5 Valence zero order molecular connectivity index (0vv) Topological
6 Valence ﬁrst order molecular connectivity index (1vv) Topological
7 Valence second order molecular connectivity index (2vv) Topological
8 Kier’s alpha ﬁrst order shape indice (ja1) Topological
9 Kier’s alpha second order shape index (ja2) Topological
10 Kier’s ﬁrst order shape indice (j1) Topological
11 Randic topological index Topological
12 Balaban topological index Topological
13 Wiener’s topological index Topological
14 Kier’s second order shape index (j2) Topological
15 Ionization potential Electronic
16 Dipole moment (l) Electronic
17 Energy of highest occupied molecular orbital (HOMO) Electronic
18 Energy of lowest unoccupied molecular orbital (LUMO) Electronic
19 Total energy (Te) Electronic
20 Nuclear Energy (Nu. E) Electronic
21 Molar refractivity (MR) Steric
S886 S. Kumar et al.subtilis compound 19 emerged as potential antibacterial candi-
date (pMICbs = 1.72). Besides having good antibacterial activ-
ity, the synthesized compounds also displayed appreciable
antifungal activity and compound 10 emerged as the most ac-
tive antifungal agent against C. albicans and A. niger (pMICca
and pMICan = 1.93) which may be taken as a lead compound
for the development of novel antifungal agents.
2.3. Structure activity relationship
1. Results of antimicrobial screening indicated that esters of
propionic acid were poor antimicrobial agents than Schiff
bases except compound 19 (synthesized using benzyl alcohol)
which was found to be the most active against B. subtilis.
2. Presence of electron withdrawing group (p-Br, compound
15) improved the antibacterial activity of the synthesized
compounds against S. aureus and E. coli, whereas the pres-
ence of electron releasing trimethoxy group (3,4,5-trimeth-
oxy, compound 10) improved the antifungal activity of
the synthesized compounds against C. albicans and A.
niger.3. Schiff base synthesized using cinnamaldehyde (17) was
found to be a less active antimicrobial agent, which indi-
cates that benzylidene portion is necessary for the antimi-
crobial activity of the synthesized compounds as its
replacement by phenylallylidine moiety (compound 17)
decreases the antimicrobial activity.
4. From these results we may conclude that different struc-
tural requirements are required for a compound to be effec-
tive against different targets. This is similar to the results of
Sortino et al. (Sortino et al., 2007).
5. The abovementioned ﬁndings are summarized in Fig. 5.
2.4. QSAR studies
2.4.1. Development of multi-target QSAR models (mt-QSAR)
In the present study, we have performed the quantitative struc-
ture–activity relationship study by conventional Hansch’s
analysis using the linear free energy relationship model
(LFER) described by Hansch and Fujita (Hansch and Fujita,
Table 4 Values of selected descriptors used in QSAR studies of propionic acid derivatives.
Comp. Log P MR 1vv ja1 J W Te LUMO HOMO l
1 2.09 59.52 4.70 12.55 1.97 512.00 3009.58 1.23 9.48 5.04
2 1.89 58.66 4.72 11.95 2.05 420.00 2654.42 0.26 8.67 3.79
3 2.66 57.00 4.71 11.29 1.98 351.00 2538.71 0.50 9.02 2.95
4 1.89 58.66 4.72 11.95 1.92 434.00 2654.59 0.35 8.94 3.53
5 2.14 52.20 4.20 10.00 1.86 296.00 2178.57 0.13 8.84 4.27
6 1.60 60.36 4.86 12.91 2.00 510.00 2975.02 0.19 8.47 6.49
7 1.95 65.10 5.45 13.90 2.04 606.00 3130.80 0.16 8.44 6.59
8 1.82 58.79 4.63 11.66 1.92 448.00 2626.81 0.77 9.11 7.08
9 1.93 65.91 5.22 12.95 1.97 533.00 2710.42 0.14 8.17 4.38
10 1.38 71.59 5.78 15.86 2.23 776.00 3605.90 0.30 8.62 6.06
11 1.89 58.66 4.72 11.95 1.92 448.00 2654.45 0.10 8.53 3.18
12 2.66 57.00 4.70 11.29 1.89 358.00 2538.97 0.43 9.40 1.71
13 1.86 53.89 4.34 10.96 1.98 351.00 2499.18 0.27 8.71 5.60
14 2.66 57.00 4.70 11.29 1.90 365.00 2538.68 0.40 8.89 5.09
15 2.93 59.82 5.11 11.47 1.90 365.00 2518.18 0.47 8.95 5.09
16 2.61 57.24 4.61 11.00 1.90 365.00 2334.59 0.17 9.10 5.35
17 2.55 62.44 4.86 11.73 1.79 476.00 2461.86 0.63 8.70 4.98
18 1.71 35.78 3.32 8.63 3.06 104.00 1731.27 1.20 11.19 1.97
19 2.27 46.65 4.02 8.94 1.90 226.00 2086.67 0.22 9.69 1.65
20 1.25 31.21 2.86 7.63 3.10 71.00 1575.46 1.24 11.10 1.66
21 2.03 40.46 3.82 9.63 3.03 146.00 1887.13 1.20 11.12 1.78
22 2.08 43.05 4.52 8.72 1.95 168.00 2015.38 1.24 10.76 1.62
23 1.74 51.64 5.07 12.59 2.91 346.00 2519.55 1.18 10.89 0.32
24 1.70 35.91 3.46 8.63 2.88 110.00 1731.41 1.20 11.15 1.84
Table 5 Correlation matrix for the antifungal activity of synthesized propionic acid derivatives.
Log P MR 1vv ja1 J W LUMO HOMO l pMICaf
Log P 1.000 0.290 0.243 0.003 0.605 0.039 0.455 0.315 0.048 0.043
MR 1.000 0.921 0.920 0.729 0.957 0.810 0.874 0.680 0.799
1vv 1.000 0.915 0.607 0.893 0.568 0.679 0.481 0.847
ja1 1.000 0.427 0.971 0.608 0.691 0.573 0.863
J 1.000 0.557 0.798 0.823 0.582 0.431
W 1.000 0.716 0.786 0.698 0.828
LUMO 1.000 0.839 0.709 0.499
HOMO 1.000 0.761 0.555
l 1.000 0.498
pMICaf 1.000
Synthesis, antimicrobial evaluation and QSAR studies of propionic acid derivatives S8871964). In this approach, structural features of drug molecules
are quantiﬁed in terms of different parameters and these struc-
tural features are correlated with quantiﬁed biological activity
through equation using regression analysis. Biological activity
data determined as MIC values were ﬁrst transformed into
pMIC values (i.e. –log MIC) and used as dependent variables
in QSAR study.
The different molecular descriptors selected for the present
study are listed in Table 3. Molecular descriptors (independent
variables) like log of octanol–water partition coefﬁcient (log
P), molar refractivity (MR), Kier’s molecular connectivity
(0v, 0vv, 1v, 1vv, 2v, 2vv) and shape (j1, ja1, ja2, ja3) topolog-
ical indices, Randic topological index (R), Balaban topological
index (J), Wiener topological index (W), Total energy (Te),
energies of highest occupied molecular orbital (HOMO) and
lowest unoccupied molecular orbital (LUMO), dipole moment
(l) and electronic energy (Ele.E) (Hansch et al., 1973; Kier and
Hall, 1976; Randic 1975, 1993; Balaban 1982; Wiener 1947)
were calculated for propionic acid derivatives and the values
of selected descriptors are presented in Table 4.From the results of our previous QSAR studies (Narang
et al., 2012a; Judge et al., 2012; Kumar et al., 2010; Kumar
et al., 2009), we observed that multi-target QSAR (mt-QSAR)
models gave better results than one-target QSAR (ot-QSAR)
models in describing the antimicrobial activity. So, in light of
our past experiences, we decided to develop multi-target
QSAR models directly to describe the antimicrobial activity
of synthesized propionic acid derivatives in the present study.
According to ot-QSAR models one should use ﬁve different
equations to predict the activity of a new compound against
ﬁve microbial species. The ot-QSAR models, which are found
in most of the literature, become impractical to use when we
have to predict each compound’s results for more than one tar-
get. In these cases we have to develop one ot-QSAR model for
each target. In opposition to ot-QSAR, the mt-QSAR model is
a single equation that considers the nature of molecular
descriptors which are common and essential for describing
antibacterial and antifungal activities (Prado-Prado et al.,
2008; Gonzalez-Diaz and Prado-Prado, 2008; Cruz-Monte-
agudo et al., 2007; Gonzalez-Diaz et al., 2007).
Table 6 Correlation of different molecular descriptors with
antimicrobial activity of propionic acid derivatives.
Descriptor pMICab pMICaf pMICam
Cos E 0.343 0.576 0.543
Log P 0.239 0.043 0.150
MR 0.466 0.799 0.748
0v 0.397 0.827 0.730
0vv 0.459 0.858 0.781
1v 0.425 0.818 0.739
1vv 0.537 0.847 0.815
2v 0.377 0.761 0.678
2vv 0.469 0.751 0.719
3v 0.031 0.375 0.254
3vv 0.169 0.006 0.091
j1 0.399 0.844 0.742
j2 0.434 0.752 0.702
j3 0.124 0.131 0.147
j2a1 0.417 0.863 0.763
j2a2 0.432 0.715 0.677
j2a3 0.092 0.063 0.087
R 0.425 0.818 0.739
J 0.352 0.431 0.456
W 0.413 0.828 0.739
Te 0.371 0.852 0.733
Ee 0.367 0.835 0.719
Ne 0.365 0.829 0.715
SA 0.493 0.864 0.804
IP 0.390 0.555 0.554
LUMO 0.203 0.499 0.422
HOMO 0.390 0.555 0.554
l 0.350 0.498 0.497
Table 7 Observed, predicted and residual antimicrobial activities of
models.
Comp. pMICab pMICa
Obs. Pre. Res. Obs.
1 1.15 1.30 0.15 1.55
2 1.22 1.30 0.08 1.52
3 1.33 1.30 0.03 1.38
4 1.32 1.30 0.02 1.67
5 1.25 1.26 0.01 1.30
6 1.45 1.32 0.13 1.70
7 1.38 1.36 0.02 1.73
8 1.31 1.30 0.01 1.66
9 1.04 1.35 0.31 1.70
10 1.33 1.39 0.06 1.93
11 1.22 1.30 0.08 1.52
12 1.23 1.30 0.07 1.68
13 1.19 1.27 0.08 1.49
14 1.43 1.30 0.13 1.68
15 1.61 1.34 0.27 1.76
16 1.38 1.29 0.09 1.48
17 1.41 1.32 0.09 1.51
18 1.02 1.19 0.17 1.17
19 1.42 1.25 0.17 1.57
20 1.27 1.15 0.12 1.12
21 1.16 1.23 0.07 1.06
22 1.30 1.29 0.01 1.40
23 1.38 1.33 0.05 1.63
24 1.22 1.20 0.02 1.47
S888 S. Kumar et al.In order to develop mt-QSAR models, initially we have cal-
culated the average antibacterial, antifungal and antimicrobial
activity values of propionic acid derivatives which are pre-
sented in Table 2. The standard drugs norﬂoxacin and ﬂuco-
nazole were not included in the model generation because of
dissimilarity in structure with synthesized compounds.
In the present study, a data set of 24 compounds was sub-
jected to single/multiple linear free energy regression analysis
for model generation. Compounds 9, 15, 19 and 21 were des-
ignated as outliers and were not included in the data set for
QSAR model generation. In multivariate statistics, it is com-
mon to deﬁne three types of outliers (Furusjo et al., 2006).
1. X/Y relation outliers are substances for which the relation-
ship between the descriptors (X variables) and the depen-
dent variables (Y variables) is not the same as in the (rest
of the) training data.
2. X outliers are substances whose molecular descriptors do
not lie in the same range as in the (rest of the) training data.
3. Y outliers are only deﬁned for training or test samples.
They are substances for which the reference value of
response is invalid.
There was no difference in the activity (Table 2) as well as
the molecular descriptor range (Table 3) of these outliers (9,
15, 19 and 21) when compared to other propionic acid
derivatives indicating the fact that these outliers belong to
the category of Y outliers (Substances for which the reference
value of response is invalid).
Preliminary analysis was carried out in terms of correlation
analysis. A correlation matrix constructed for antifungalthe synthesized propionic acid derivatives obtained by mtQSAR
f pMICam
Pre. Res. Obs. Pre. Res.
1.64 0.09 1.31 1.41 0.10
1.58 0.06 1.34 1.41 0.07
1.53 0.15 1.35 1.41 0.06
1.58 0.09 1.46 1.41 0.05
1.41 0.11 1.27 1.33 0.06
1.67 0.03 1.55 1.43 0.12
1.75 0.02 1.52 1.52 0.00
1.56 0.10 1.45 1.40 0.05
1.67 0.03 1.30 1.49 0.18
1.92 0.01 1.57 1.57 0.00
1.58 0.06 1.34 1.41 0.07
1.53 0.15 1.41 1.41 0.00
1.50 0.01 1.31 1.35 0.04
1.53 0.15 1.53 1.41 0.12
1.54 0.22 1.67 1.47 0.20
1.50 0.02 1.42 1.39 0.03
1.56 0.05 1.45 1.43 0.02
1.30 0.13 1.08 1.20 0.12
1.32 0.25 1.48 1.31 0.17
1.21 0.09 1.21 1.14 0.07
1.38 0.32 1.12 1.28 0.16
1.30 0.10 1.34 1.38 0.04
1.64 0.01 1.48 1.46 0.02
1.30 0.17 1.32 1.23 0.09
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2.01.81.61.41.21.0
Pr
ed
ic
te
d 
pM
IC
af
2.0
1.8
1.6
1.4
1.2
Figure 6 Plot of predicted pMICaf values against observed
pMICaf values for the linear regression model developed (Eq. 1).
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Figure 7 Plot of residual pMICaf values against observed
pMICaf values for the linear regression model developed (Eq. 1).
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Figure 8 Plot of predicted pMICam values against observed
pMICam values for the linear regression model developed (Eq. 3).
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Figure 9 Plot of residual pMICam values against observed
pMICam values for the linear regression model developed (Eq. 3).
Synthesis, antimicrobial evaluation and QSAR studies of propionic acid derivatives S889activity is presented in Table 5. In general, high collinearity
(r> 0.5) was observed between different parameters. The high
interrelationship was observed between W and ja1 (r= 0.971)
and low interrelationship was observed between ja1 and log P
(r= 0.003). The correlation of antibacterial, antifungal and
antimicrobial activities with calculated molecular descriptors
is given in Table 6.
The structural effects on variations in the antifungal activ-
ity of the propionic acid derivatives in terms of pMICaf were
examined by regression analysis with molecular parameters
as shown in Table 4. For 20 propionic acid derivatives, Eq.
(1) was derived as that of the best quality using the topological
parameter, Kier’s alpha ﬁrst order shape index (ja1).
LR mt-QSAR model for antifungal activity
pMICaf ¼ 0:0867ja1 þ 0:547 ð1Þ
n ¼ 20 r ¼ 0:863 q2 ¼ 0:686 s ¼ 0:101 F ¼ 52:46Here and thereafter, n – number of data points, r – correlation
coefﬁcient, q2 – cross validated r2 obtained by leave one out
method, s – standard error of the estimate and F – Fischer
statistics.
The coefﬁcient of ja1 in Eq. (1) is positive which signiﬁes
that the antifungal activity of synthesized compounds will in-
crease with an increase in the value of ja1. This is evidenced
by the antifungal activity data of propionic acid derivatives
(Table 2) and their ja1 values (Table 4). Compound 10 having
the highest ja1 value (15.86, Table 4) has the maximum anti-
fungal activity with a pMICaf value of 1.93 (Table 2) and com-
pound 21 having a low ja1 value (9.63, Table 4) has the
minimum antifungal activity with a pMICaf value 1.06
(Table 2).
In order to account for the variation in size contribution to
shape from different atoms the radius of atom X relative to the
covalent radius of a carbon sp3 hybrid atom is considered. The
speciﬁc correction in computing 1j is made by modifying the
S890 S. Kumar et al.count of atoms, n, with a modiﬁer, a, calculated as: aX = (rX/
rcsp3)
1.
where a represents a decrement or increment of n for a non-
carbon sp3 element X. The modiﬁed kappa shape indices are
given by (Kier and Hall, 1999):
ja1 ¼ ðnþ aÞðnþ a 1Þ2=ð1Pi þ aÞ2
ja2 ¼ ðnþ a 1Þðnþ a 2Þ2=ð2Pi þ aÞ2
ja3 ¼ ðnþ a 1Þðnþ a 3Þ2=ð3Pi þ aÞ2n is odd
ja3 ¼ ðnþ a 3Þðnþ a 2Þ2=ð3Pi þ aÞ2n is even
The developed QSAR model (Eq. (1)) was cross validated by
its high q2 value (q2 = 0.686) obtained by leave one out
(LOO) method. The value of q2 more than 0.5 indicated that
the developed model is a valid one (Golbraikh and Tropsha,
2002). Further the observed and predicted values are close to
each other (Table 7), the mt-QSAR model for antifungal activ-
ity (Eq. (1)) is a valid one. The plot of predicted pMICaf
against observed pMICaf (Fig. 6) also favours the developed
model expressed by Eq. (1). Further, the plot of observed
pMICaf vs residual pMICaf (Fig. 7) indicated that there was
no systemic error in model development as the propagation
of error was observed on both sides of zero (Kumar et al.,
2007).
The antibacterial activity of propionic acid derivatives is
best described by the topological parameter, valence ﬁrst order
molecular connectivity index (1vv, Table 6, Eq. (2)). Hence, the
QSAR model for antibacterial activity was developed using
1vv.
LR mt-QSAR model for antibacterial activity
pMICab ¼ 0:08361vv þ 0:909 ð2Þ
n ¼ 20 r ¼ 0:536 q2 ¼ 0:0174 s ¼ 0:0914 F ¼ 7:28
Antibacterial activity of synthesized propionic acid derivatives
is positively correlated with valence ﬁrst order molecular con-
nectivity index (1vv) which means that antibacterial potential
of synthesized compounds will increase with increase in 1vv
values (Tables 2 and 4).
A less signiﬁcant (poor) correlation was observed between
calculated molecular descriptors and antibacterial activity of
the synthesized propionic acid derivatives as evidenced by
low q2 value (0.0174, Eq. (2)).
In the case of antimicrobial activity also valence ﬁrst order
molecular connectivity index (1vv, Table 5) emerged as the
most determinant parameter (Eq. (3)).
LR mt-QSAR model for antimicrobial activity
pMICam ¼ 0:1481vv þ 0:714 ð3Þ
n ¼ 20 r ¼ 0:815 q2 ¼ 0:554 s ¼ 0:0730 F ¼ 35:55
Antimicrobial activity of synthesized propionic acid deriva-
tives is also positively correlated with valence ﬁrst order molec-
ular connectivity index (1vv) which means that antimicrobial
potential of synthesized compounds will increase with increase
in 1vv values (Tables 2 and 4).
The molecular connectivity index, an adjacency based topo-
logical index proposed by Randic is denoted by v and is de-
ﬁned as the sum over all the edges (ij) as per the following
v ¼
Xn
i¼1
ðViVjÞ1=2where Vi and Vj are the degrees of adjacent vertices i and j and
n is the number of vertices in a hydrogen suppressed molecular
structure (Lather and Madan, 2005). The topological index, v
signiﬁes the degree of branching, connectivity of atoms and
unsaturation in the molecule which accounts for variation in
activity (Gupta et al., 2003).
The validity and predictability of the QSAR model (Eq. (3))
is evidenced by its high q2 the low residual antimicrobial activ-
ity values (Table 7). The plot of predicted pMICam against ob-
served pMICam (Fig. 8) also favours the developed model
expressed by Eq. (3). Further, the plot of observed pMICam
vs residual pMICam (Fig. 9) indicated that there was no sys-
temic error in model development as the propagation of error
was observed on both sides of zero (Kumar et al., 2007). The
high residual activity value in the case of compounds 9, 15,
19 and 21 justiﬁes their removal as outliers.
It was observed from mt-QSAR models [Eqs. (1)–(3)] that
the antibacterial, antifungal and overall antimicrobial activi-
ties of synthesized propionic acid derivatives were governed
by the topological parameters, Kier’s alpha ﬁrst order shape
index (ja1) and valence ﬁrst order molecular connectivity in-
dex (1vv).
Generally for QSAR studies, the biological activities of
compounds should span 2–3 orders of magnitude. But in the
present study the range of antimicrobial activities of the syn-
thesized compounds is within one order of magnitude. This
is similar to the results obtained by Bajaj et al. (Bajaj et al.,
2005) who stated that the reliability of the QSAR model lies
in its predictive ability even though the activity data are in
the narrow range. The low residual values observed in Table 7
justify the QSAR studies with the synthesized propionic acid
derivatives. When biological activity data lie in the narrow
range, the presence of a minimum standard deviation of the
biological activity justiﬁes its use in QSAR studies
(Narasimhan et al., 2007). The minimum standard deviation
(Table 2) observed in the antimicrobial activity data justiﬁes
its use in QSAR studies.
3. Experimental
Starting materials were obtained from Himedia Chemicals and
were used without further puriﬁcation. Melting points were
determined in open glass capillaries on a sonar melting point
apparatus and are uncorrected. Reaction progress was moni-
tored by thin layer chromatography on silica gel sheets (Merck
silica gel –G). 1H nuclear magnetic resonance (1H NMR) spec-
tra were recorded on Bruker Avance II 400 NMR spectrome-
ter (400 MHz) at 298 K, in appropriate deuterated solvents.
Chemical shifts were reported as d (ppm) relative to tetrameth-
ylsilane (TMS) as internal standard. Infrared (IR) spectra were
recorded as KBr pellet on Perkin Elmer FTIR spectrometer.
The wave number is given in cm1. Elemental analysis was per-
formed on a Perkin–Elmer 2400 C, H, N analyser.
3.1. General procedure for the synthesis of esters of propionic
acid
A mixture of propionic acid (0.08 mol) and different alcohols
(0.74 mol) was reﬂuxed in the presence of sulphuric acid till
the completion of reaction. Once the reaction had been com-
pleted, the reaction mixture was added to 200 ml ice cold water
Synthesis, antimicrobial evaluation and QSAR studies of propionic acid derivatives S891and the ester formed was extracted with ether (50 ml). The
ether layer was separated which on evaporation yielded the es-
ter derivatives of propionic acid.3.2. General procedure for the synthesis of Schiff bases of
propionic acid
Hydrazine-hydrate (99%, 0.015 mol) was added to ethanolic
solution of ethyl propionate (0.01 mol) and reﬂuxed for
3–4 h. The reaction mixture was then cooled and the
precipitate was ﬁltered off, washed with water, dried and
recrystallized from ethanol. A solution of different aldehydes
(0.05 mol) in ethanol was added to a solution of propionic acid
hydrazide (synthesized above, 0.05 mol) in 50 mL ethanol and
reﬂuxed for 5 h. Then the reaction mixture was allowed to cool
at room temperature and the precipitated hydrazone was ﬁl-
tered, dried and recrystallized from ethanol.
Compound 1. Mp (C) 173–175; Yield – 65.23%; (KBr pel-
lets)cm1: 1632 (C‚O str., 20 amide), 1519 (NO2 str.), 832 (C–
N str., –NO2), 1075 (N–N str., –NHN‚CH), 3086 (C–H str.,
phenyl); 1H NMR(DMSO): 7.120–8.385 (m, 4H, ArH), 8.416
(s, 1H, N‚CH), 2.51 (m, 2H, CH2 of C2H5), 1.190 (t, 3H,
CH3 of C2H5); Analysis Calculated for C10H11N3O3: C,
54.29; H, 5.01; N, 19.00; Found; C, 54.33; H, 5.05; N, 19.04;
Compound 9: Mp (C) 222–225; Yield – 90–12%; (KBr pel-
lets)cm1: 2909 (CH str.(asym), R–CH3), 1597 (C‚O str., 2
0
amide), 1062 (N–N str., –NHN‚CH), 1518 (C‚C skeletal
str., phenyl); 1H NMR(DMSO): 6.751–7.700 (m, 4H, ArH),
8.506 (s, 1H, N‚CH), 2.507 (m, 2H, CH2 of C2H5), 2.994
(s, 6H, –N(CH3)2); Analysis Calculated for C12H17N3O: C,
65.73; H, 7.81; N, 19.16; Found; C, 65.76; H, 7.78; N, 19.19;
Compound 10: Mp (C) 158–160; Yield – 75–20%; (KBr pel-
lets)cm1: 2934 (CH str.(asym), R–CH3), 2839 (CH str.
(sym), R–CH3), 1694 (C‚O str., 2
0 amide), 1621 (C‚N str.,
N‚CH), 1125 (N–N str., –NHN‚CH), 1504 (C‚C skeletal
str., phenyl), 2934 (C–H str., OCH3), 1230(C–O–C str.,
OCH3);
1H NMR(DMSO): 7.227(m, 2H, ArH), 8.65(s, 1H,
N‚CH), 2.512(m, 2H, CH2 of C2H5), 3.855(s, 9H, Ar–
OCH3); Analysis Calculated for C13H18N2O4: C, 58.63; H,
6.81; N, 10.52; Found; C, 58.59; H, 6.84; N, 10.55; Compound
11: Mp (C) 141–143; Yield – 89.01%; (KBr pellets)cm1: 1601
(C‚N str., N‚CH), 1023 (N–N str., –NHN‚CH), 1506
(C‚C skeletal str., phenyl), 1249 (C–O–O str., OCH3);
1H
NMR(DMSO): 7.041–7.832(m, 4H, ArH), 8.633(s, 1H,
N‚CH), 2.51(m, 2H, CH2 of C2H5), 3.830(s, 3H, Ar –
OCH3); Analysis Calculated for C11H14N2O2: C, 64.06; H,
6.84; N, 13.58; Found; C, 64.10; H, 6.92; N, 13.61; Compound
17: Mp (C) 139–141; Yield – 70.31%; (KBr pellets)cm1: 2923
(CH str. (asym), R–CH3), 1628 (C‚O str., 2
0 amide), 1586
(C‚N str., N‚CH), 1073 (N–N str.,–NHN‚CH), 3038
(C–H str., phenyl nucleus), 1486 (C‚C skeletal str., phenyl);
1H NMR(DMSO): 7.790–8.380 (m, 5H, ArH), 8.628 (s, 1H,
N‚CH), 2.523 (m, 2H, CH2 of C2H5); Analysis Calculated
for C12H14N2O: C, 71.26; H, 6.98; N, 13.85; Found; C,
71.21; H, 6.95; N, 13.88; Compound 21: Mp (C) 117–120;
Yield – 67.60%; (KBr pellets)cm1: 2956 (CH str. (asym),
R–CH3), 1721 (C‚O str., of ester).;
1H NMR(DMSO):
1.072 (t, 3H, CH3 of propionate), 2.292 (m, 2H, CH2 of propi-
onate), 1.012 (d, 6H, CH3 of isopentyl), 1.716 (m, 1H, CH of
isopentyl), 1.503 (m, 2H(C2) of isopentyl), 4.064 (t, 2H,
CH2(C1) of isopentyl); Analysis Calculated for C8H16O2: C,66.63; H, 11.18; Found; C, 66.69; H, 66.73; Compound 22:
Bp (C) 123–125; Yield – 85.34%; (KBr pellets)cm1: 2929
(CH str.(asym), R–CH3), 1716 (C‚O str., of ester), 1065 (ring
str., cyclohexane); 1H NMR(DMSO): 1.148 (t, 3H, CH3 of
propionate), 2.305(m, 2H, CH2 of propionate), 1.181–2.280
(m, 6H, cyclohexane); Analysis Calculated for C9H16O2: C,
69.19; H, 10.32; Found; C, 69.24; H, 10.35; Compound 23:
Bp (C) 130–132; Yield – 78.12%; (KBr pellets)cm1: 2924
(CH str.(asym), R–CH3), 1681 (C‚O str., of ester), 1012(C–
O str. and O–H in plane bending); 1H NMR(DMSO): 1.087
(t, 3H, CH3 of propionate), 2.294 (m, 2H, CH2 of propionate),
4.003 (t, 2H, CH2(C1) of heptyl), 1.553 (m, 2H(C2) of heptyl),
1.253 (m, 6H(C3, C4, C5) of heptyl), 1.530 (m, CH2(C6) of hep-
tyl), 3.386 (m, 2H, CH2(C7) of heptyl), 2.219 (t, 1H, OH);
Analysis Calculated for C10H20O3: C, 63.80; H, 10.71; Found;
C, 63.84; H, 10.68; Compound 24: Bp (C) 138–140; Yield –
90.45%; (KBr pellets)cm1: 2933 (CH str. (asym), R-CH3),
1721 (C‚O str., of ester), 2874 (CH str., (sym), R–CH3);
1H
NMR(DMSO): 1.217 (t, 3H, CH3 of propionate), 2.305 (m,
2H, CH2 of propionate), 0.977 (t, 3H, CH3 of butyl), 1.334
(m, 2H., CH2(C3) of butyl), 1.570 (m, 2H, CH2(C2) of butyl),
4.004 (t, 2H, CH2(C1) of butyl); Analysis Calculated for
C7H14O2: C, 64.58; H, 10.84; Found; C, 64.62; H, 10.81.
3.3. Antimicrobial assay
The antimicrobial activity that was performed against Gram-
positive bacteria: S. aureus, B. subtilis, the Gram-negative bac-
terium E. coli and fungal strains: C. albicans and A. niger using
the tube dilution method (Cappucino and Sherman, 1999).
Dilutions of test and standard compounds were prepared in
double strength nutrient broth - I.P. (bacteria) or Sabouraud
dextrose broth - I.P. (fungi) (Pharmacopoeia of India, 2007).
The samples were incubated at 37 C for 24 h (bacteria), at
25 C for 7 d (A. niger) and at 37 C for 48 h (C. albicans)
and the results were recorded in terms of minimum inhibitory
concentration (MIC).
3.4. QSAR studies
The structures of propionic acid derivatives were ﬁrst pre-opti-
mized with the Molecular Mechanics Force Field (MM+) pro-
cedure included in Hyperchem 6.03 (Hyperchem 6.0, 1993) and
the resulting geometries were further reﬁned by means of the
semiempirical method PM3 (Parametric Method-3). We had
chosen a gradient norm limit of 0.01 kcal/A for the geometry
optimization. The lowest energy structure was used for each
molecule to calculate physicochemical properties using TSAR
3.3 software for Windows (TSAR 3D Version 3.3, 2000). Fur-
ther, the regression analysis was performed using the SPSS
software package (SPSS for Windows, 1999).
4. Conclusion
A series of Schiff bases (1–17) and esters (18–24) of propionic
acid was synthesized and evaluated in vitro for their anti-
microbial activity against Gram-positive bacteria S. aureus,
B. subtilis, Gram negative bacterium E. coli and fungal strains
C. albicans and A. niger by tube dilution method. Results of
antimicrobial screening indicated that in general, esters of pro-
pionic acid were poor antimicrobial agents than Schiff bases.
S892 S. Kumar et al.Schiff bases having electron withdrawing substituents on ben-
zylidene moiety were found to be better antibacterial agents
and those having electron donating substituents on benzyli-
dene moiety were found to be better antifungal agents among
which compound 10 emerged as the most potent antifungal
agent and may be taken as a lead compound for the develop-
ment of novel antifungal agents. QSAR studies were carried
out in order to ﬁnd out the relationship between antimicrobial
activity of synthesized compounds and their structures (molec-
ular descriptors) which demonstrated the importance of topo-
logical parameters, Kier’s alpha ﬁrst order shape index (ja1)
and valence ﬁrst order molecular connectivity index (1vv) in
determining the antimicrobial activity of synthesized propionic
acid derivatives.References
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